feed,title,long_url,short_url
Benzinga,BioMarin Announces Positive Phase 3 Gene Therapy Trial Results in Adults with Severe Hemophilia A; Study Met All Primary and Secondary Efficacy Endpoints in One-Year Data Set,https://www.benzinga.com/pressreleases/21/01/n19092870/biomarin-announces-positive-phase-3-gene-therapy-trial-results-in-adults-with-severe-hemophilia-a-,https://j.mp/2LHrP1q
